Korbut, A. I., Taskaeva, I. S., Bgatova, N. P., Muraleva, N. A., Orlov, N. B., Dashkin, M. V., . . . Klimontov, V. V. (2020). SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes. Int J Mol Sci.
Citação norma ChicagoKorbut, Anton I., et al. "SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in Db/db Mice, a Model of Type 2 Diabetes." Int J Mol Sci 2020.
ציטוט MLAKorbut, Anton I., et al. "SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in Db/db Mice, a Model of Type 2 Diabetes." Int J Mol Sci 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.